Cargando…
Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis
The advancement of high-throughput sequencing and genomic analysis revealed that acute lymphoblastic leukemia (ALL) is a genetically heterogeneous disease. The abundance of such genetic data in ALL can also be utilized to identify potential targets for drug discovery and even drug repurposing. We ai...
Autores principales: | Zazuli, Zulfan, Irham, Lalu Muhammad, Adikusuma, Wirawan, Sari, Nur Melani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786277/ https://www.ncbi.nlm.nih.gov/pubmed/36559013 http://dx.doi.org/10.3390/ph15121562 |
Ejemplares similares
-
Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
por: Irham, Lalu Muhammad, et al.
Publicado: (2022) -
Integrated genomic network analysis revealed potential of a druggable target for hemorrhoid treatment
por: Adikusuma, Wirawan, et al.
Publicado: (2023) -
Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis
por: Adikusuma, Wirawan, et al.
Publicado: (2022) -
Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
por: Afief, Arief Rahman, et al.
Publicado: (2022) -
Integrated genomic analysis to identify druggable targets for pancreatic cancer
por: Mugiyanto, Eko, et al.
Publicado: (2022)